Suchergebnisse - "Siena, Salvatore"

PubPharm (408)

1

A phase II/III randomized clinical trial of CisPlatin plUs Gemcitabine and Nabpaclitaxel (GAP) as pReoperative chemotherapy versus immediate resection in patIents with resecTable BiliarY Tract Cancers (BTC) at high risk for recurrence : PURITY study

enthalten in: BMC cancer | 2024

von Niger, M. | Nichetti, F. | Fornaro, L. | +34

2

A phase II/III randomized clinical trial of CisPlatin plUs Gemcitabine and Nabpaclitaxel (GAP) as pReoperative chemotherapy versus immediate resection in patIents with resecTable BiliarY Tract Cancers (BTC) at high risk for recurrence: PURITY study

enthalten in: BMC cancer | 2024

von Niger, M. | Nichetti, F. | Fornaro, L. | +34

3

Anti-EGFR Rechallenge in Patients With Refractory ctDNA RAS/BRAF wt Metastatic Colorectal Cancer : A Nonrandomized Controlled Trial

enthalten in: JAMA network open | 2024

von Ciardiello, D. | Martinelli, E. | Troiani, T. | +19

4

The role of anti-EGFR rechallenge in metastatic colorectal cancer, from available data to future developments : A systematic review

enthalten in: Cancer treatment reviews | 2024

von Ciardiello, D. | Mauri, G. | Sartore-Bianchi, A. | +4

5

Brief Report : Updated Efficacy and Safety Data From an Integrated Analysis of Entrectinib in Locally Advanced/Metastatic ROS1 Fusion-Positive Non-Small-Cell Lung Cancer

enthalten in: Clinical lung cancer | 2024

von Fan, Y. | Drilon, A. | Chiu, C. | +7

6

Tolerance to colibactin correlates with homologous recombination proficiency and resistance to irinotecan in colorectal cancer cells

enthalten in: Cell reports. Medicine | 2024

von Sogari, A. | Rovera, E. | Grasso, G. | +20

7

Ongoing Clinical Trials and Future Research Scenarios of Circulating Tumor DNA for the Treatment of Metastatic Colorectal Cancer

enthalten in: Clinical colorectal cancer | 2024

von Roazzi, L. | Patelli, G. | Bencardino, K. | +10

8

Clinicopathological characterisation of MTAP alterations in gastrointestinal cancers

enthalten in: Journal of clinical pathology | 2024

von Mauri, G. | Patelli, G. | Roazzi, L. | +13

9

Targeting HER2 heterogeneity in breast and gastrointestinal cancers

enthalten in: Trends in cancer | 2024

von Valenza, C. | Guidi, L. | Battaiotto, E. | +4

10

Characteristics and Survival Outcomes of Patients With Metastatic RET Fusion-Positive Solid Tumors Receiving Non-RET Inhibitor Standards of Care in a Real-World Setting

enthalten in: JCO precision oncology | 2024

von Hackshaw, A. | Fajardo, O. | Dafni, U. | +6

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[41]